PEFICITINIB: A PROMISING HOPE FOR AUTOIMMUNE JOINT DISEASE?

Peficitinib, a novel medication targeting SYK , presents a significant step in the management of RA . Early research trials indicate that it appears to noticeably alleviate swelling and bolster physical capabilities in people who suffer from the disease , especially those who don't shown improvem